QBIOTICS REPORTS 80% OBJECTIVE RESPONSE RATE IN INJECTED TUMOURS IN STAGE 1 OF PHASE IIA CLINICAL TRIAL OF TIGILANOL TIGLATE FOR SOFT TISSUE SARCOMA
BRISBANE, Australia, June 25, 2025 /PRNewswire/ -- QBiotics CEO, Stephen Doyle, reflecting on Soft Tissue Sarcoma data Positive data from Stage 1 of the Phase IIa clinical trial (QB46C-H07) evaluating QBiotics' small molecule, tigilanol tiglate in...
CPA Australia survey: Young entrepreneurs help drive robust growth in Filipino small business sector
MANILA, Philippines, May 28, 2025 /PRNewswire/ -- Filipino small businesses continue to stand out as among the most dynamic in the Asia Pacific region, with 77 per cent reporting growth in 2024 and 89 per cent expecting to expand this year. CPA...
Cutting-Edge Industrial Cluster Lights Up Northern Vietnam: A New Map of Opportunities Emerges
RSQUARE Vietnam Analysis: "Bac Ninh-Bac Giang-Hung Yen Industrial Belt Rising as a New Hub for Global Enterprises" Industrial Park Prices Up by 7% YoY; Rental Rates for Factories Also Soaring RSQUARE Vietnam to Host Investment Seminar on December 17...